RIGL ▲ +0.0% - Rigel Pharmaceuticals, Inc.
$RIGL RIGL - Rigel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Lower-Risk MDS at the 68th American Society of Hematology Annual Meeting and Exposition
04-NOV-2026 09:15 AM ET
Share this post
More filings for $RIGL
RIGL ▲ +0.8% - Rigel Pharmaceuticals, Inc.Oct 29, 2026RIGL ▲ +0.3% - Rigel Pharmaceuticals, Inc.Oct 2, 2026RIGL ▲ +0.1% - Rigel Pharmaceuticals, Inc.Sep 2, 2026RIGL - Rigel Pharmaceuticals, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026RIGL - Rigel Pharmaceuticals, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $RIGL filing history →💬 Comments
Loading comments…
Leave a comment